Bastiaan Jeroen van der Baan - 30 Dec 2022 Form 4/A - Amendment Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

Role
Director
Signature
/s/ Bastiaan van der Baan
Issuer symbol
LIXT
Transactions as of
30 Dec 2022
Net transactions value
+$4,900
Form type
4/A - Amendment
Filing time
05 Jan 2023, 10:00:14 UTC
Date Of Original Report
04 Jan 2023
Previous filing
18 Jul 2022
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIXT Common Stock Purchase $4,900 +10,000 $0.4900 10,000 30 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Amended Form 4 corrects the purchase price of the shares covered by the Form 4 filed on January 4, 2023.